Biotech

All Articles

James Wilson leaving Penn to launch 2 brand new biotechs

.After greater than three decades, gene treatment innovator James Wilson M.D., Ph.D., is actually le...

3 biotechs make an effort to beat the summer heat energy by shedding personnel

.As biotechs try to switch a new webpage in August, at the very least 3 business have shed workers i...

venBio raises $528M for fifth lifestyle sciences VC fund

.Expert financial backing company venBio has actually raised an additional half a billion bucks to p...

Otsuka pays $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 thousand so the Eastern biotech...

FibroGen gives up 75% people staff as possession flunks 2 more tests

.FibroGen is substantially reorganizing its service, giving up 75% of its USA team and quiting asset...

Tracon wane full weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has decided to unwind operations weeks after an injectable immune system che...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy drug, touts FDA manage

.We currently recognize that Takeda is hoping to find a pathway to the FDA for epilepsy medicine sot...

VBI Injections apply for insolvency, finds possession sale

.Immunology biotech VBI Vaccinations is turning alarmingly near the point of no return, along with p...

Celldex anti-cKIT antitoxin minimize hives in yet another phase 2 research

.It's hard to muscle in on an area as affordable as immunology, however Celldex Rehabs believes that...